iBIO has partnered with G2G Consulting to identify SBIR/STTR and other Government Non-Dilutive Grant opportunities for iBIO Members. Our goal is to increase funding opportunities in Illinois and the utilization of federal grants to support research and small company creation.
Every month we will provide a Government Bioscience Grants Report. This month’s report is published and available for iBIO members to access through G2G’s website:
Password: G2GBio17 (case sensitive)
SBIR/STTR: Note some opportunities for FDA submission, IP strategy, planning for clinical trial, independent replication of key studies, IND-enabling studies, clinical studies, manufacturing costs, regulatory assistance:
- NIH/CDC (p. 20, #54) – Contains opportunities to submit a proposal on close to 40 different topics. Some allow for only a Phase I proposal. Others only allow ‘Direct to Phase II’ and there are some ‘Fast Track’ opportunities, which include both Phase I and Phase II. Click on thislink to see full topic list (scroll to pp. 1-3 of the announcement); full descriptions of each topic can be found by scrolling to p. 66 of the announcement. A few topics listed below to give you sense of what’s there:
- Tools and technology for visualizing multi-scale data
- Software enabling data interpretation from wearable sensors for cancer patients
- Adjuvant discovery of vaccines against infectious or immune-mediated diseases
- Several cancer related topics
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (p.21, #55) – aims to facilitate transition of previously funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance not typically supported through Phase II or Phase IIB grants or contracts.This may include preparation of documents for a FDA submission, development of an intellectual property strategy, and/or planning for a clinical trial.Clinical trials not accepted under this FOA.
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (p.21, #56) – aims to facilitate the transition of previously or currently funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance and later stage research and development not typically supported through Phase II or Phase IIB grants or contracts. This may include independent replication of key studies, Investigational New Drug (IND)-enabling studies, clinical studies, manufacturing costs, regulatory assistance, or a combination of services.
August GBG Topic Areas:
Addiction/Substance Abuse (7)
Alzheimer’s Disease (4)
Broad Agency Announcements (14)
Heart, Lung, and Blood (4)
Infectious Disease (2)
Pain Management (1)
Transplant Research (1)
Traumatic Brain Injury (4)